| Literature DB >> 29692721 |
Zhuqing Long1, Bin Jing2, Ru Guo3, Bo Li4, Feiyi Cui1, Tingting Wang1, Hongwen Chen1.
Abstract
Mild cognitive impairment (MCI), which generally represents the transition state between normal aging and the early changes related to Alzheimer's disease (AD), has drawn increasing attention from neuroscientists due that efficient AD treatments need early initiation ahead of irreversible brain tissue damage. Thus effective MCI identification methods are desperately needed, which may be of great importance for the clinical intervention of AD. In this article, the range scaled analysis, which could effectively detect the temporal complexity of a time series, was utilized to calculate the Hurst exponent (HE) of functional magnetic resonance imaging (fMRI) data at a voxel level from 64 MCI patients and 60 healthy controls (HCs). Then the average HE values of each region of interest (ROI) in brainnetome atlas were extracted and compared between MCI and HC. At last, the abnormal average HE values were adopted as the classification features for a proposed support vector machine (SVM) based identification algorithm, and the classification performance was estimated with leave-one-out cross-validation (LOOCV). Our results indicated 83.1% accuracy, 82.8% sensitivity and 83.3% specificity, and an area under curve of 0.88, suggesting that the HE index could serve as an effective feature for the MCI identification. Furthermore, the abnormal HE brain regions in MCI were predominately involved in left middle frontal gyrus, right hippocampus, bilateral parahippocampal gyrus, bilateral amygdala, left cingulate gyrus, left insular gyrus, left fusiform gyrus, left superior parietal gyrus, left orbital gyrus and left basal ganglia.Entities:
Keywords: Hurst exponent; brainnetome atlas; mild cognitive impairment; range scaled analysis; support vector machine
Year: 2018 PMID: 29692721 PMCID: PMC5902491 DOI: 10.3389/fnagi.2018.00103
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Participants’ demographic and clinical characteristics.
| Characteristics | MCI | HC | |
|---|---|---|---|
| Gender (M/F) | 64 (28/36) | 60 (26/34) | 0.96# |
| Age (years) | 67.14 ± 7.33 | 65.27 ± 7.30 | 0.16* |
| Education (years) | 9.73 ± 4.24 | 10.07 ± 4.27 | 0.66* |
| CDR | 0.5 | 0 | 0* |
| MMSE | 23.16 ± 2.77 | 27.40 ± 3.15 | <0.001* |
| AVLT-immediate recall | 7.99 ± 2.60 | 12.94 ± 2.94 | <0.001* |
| AVLT-delay recall | 3.64 ± 2.89 | 9.77 ± 2.79 | <0.001* |
| AVLT-recognition | 7.11 ± 3.55 | 11.58 ± 2.23 | <0.001* |
Values are mean ± SD unless the SD was not calculated. M, male; F, female. CDR, Clinical Dementia Rating scale; MMSE, Mini-Mental State Examination; AVLT, Auditory Verbal Learning Test. .
Figure 1The detailed brainnetome atlas which including 210 cortical sub-regions and 36 subcortical sub-regions.
Figure 2A flowchart of the proposed support vector machine (SVM)-based classification method for mild cognitive impairment (MCI) identification.
Figure 3(A) The relationship between the Mini-Mental State Examination (MMSE) score of MCI patients and prediction values; (B) receiver operating characteristics curve of the proposed classification method, and the area under curve is 0.88.
The number of features retained in per fold of leave-one-out cross-validation (LOOCV) with brainnetome atlas.
| Fold | No. of features | Fold | No. of features | Fold | No. of features | Fold | No. of features |
|---|---|---|---|---|---|---|---|
| 1 | 16 | 32 | 17 | 63 | 15 | 94 | 15 |
| 2 | 15 | 33 | 16 | 64 | 16 | 95 | 15 |
| 3 | 17 | 34 | 16 | 65 | 15 | 96 | 15 |
| 4 | 17 | 35 | 14 | 66 | 14 | 97 | 15 |
| 5 | 16 | 36 | 15 | 67 | 16 | 98 | 15 |
| 6 | 16 | 37 | 14 | 68 | 16 | 99 | 15 |
| 7 | 16 | 38 | 15 | 69 | 15 | 100 | 16 |
| 8 | 15 | 39 | 15 | 70 | 16 | 101 | 14 |
| 9 | 15 | 40 | 16 | 71 | 15 | 102 | 15 |
| 10 | 15 | 41 | 16 | 72 | 16 | 103 | 16 |
| 11 | 15 | 42 | 15 | 73 | 14 | 104 | 14 |
| 12 | 15 | 43 | 14 | 74 | 15 | 105 | 15 |
| 13 | 14 | 44 | 14 | 75 | 14 | 106 | 14 |
| 14 | 16 | 45 | 16 | 76 | 16 | 107 | 15 |
| 15 | 16 | 46 | 16 | 77 | 16 | 108 | 16 |
| 16 | 15 | 47 | 16 | 78 | 17 | 109 | 15 |
| 17 | 14 | 48 | 15 | 79 | 16 | 110 | 16 |
| 18 | 15 | 49 | 14 | 80 | 16 | 111 | 16 |
| 19 | 15 | 50 | 17 | 81 | 16 | 112 | 15 |
| 20 | 15 | 51 | 15 | 82 | 16 | 113 | 15 |
| 21 | 16 | 52 | 14 | 83 | 15 | 114 | 17 |
| 22 | 15 | 53 | 14 | 84 | 14 | 115 | 15 |
| 23 | 16 | 54 | 14 | 85 | 16 | 116 | 16 |
| 24 | 15 | 55 | 14 | 86 | 16 | 117 | 14 |
| 25 | 17 | 56 | 15 | 87 | 16 | 118 | 14 |
| 26 | 15 | 57 | 16 | 88 | 14 | 119 | 15 |
| 27 | 16 | 58 | 16 | 89 | 16 | 120 | 15 |
| 28 | 16 | 59 | 15 | 90 | 14 | 121 | 16 |
| 29 | 16 | 60 | 16 | 91 | 16 | 122 | 15 |
| 30 | 14 | 61 | 16 | 92 | 16 | 123 | 15 |
| 31 | 14 | 62 | 14 | 93 | 15 | 124 | 14 |
Figure 4The brain regions with abnormal hurst exponent (HE) values in MCI patients by using brainnetome atlas.
Figure 5The Fisher score values of these abnormal HE features which were retained no less than 118 times (124 × 0.95, 124 is the total number of the samples) in the whole leave-one-out cross-validation (LOOCV) process.